Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease

Natalia Cecilia Prymaczok,Pablo Nicolas De Francesco,Samanta Mazzetti,Marie Humbert-Claude,Liliane Tenenbaum,Graziella Cappelletti,Eliezer Masliah,Mario Perello,Roland Riek,Juan Atilio Gerez

DOI: https://doi.org/10.1038/s41531-023-00618-6

2024-01-06

Abstract:Abstract Parkinson’s disease is characterized by a progressive accumulation of alpha-Synuclein (αSyn) neuronal inclusions called Lewy bodies in the nervous system. Lewy bodies can arise from the cell-to-cell propagation of αSyn, which can occur via sequential steps of secretion and uptake. Here, by fusing a removable short signal peptide to the N-terminus of αSyn, we developed a novel mouse model with enhanced αSyn secretion and cell-to-cell transmission. Expression of the secreted αSyn in the mouse brain was under the control of a novel hybrid promoter in combination with adeno-associated virus serotype 9 (AAV9). This combination of promoter and viral vector induced a robust expression in neurons but not in the glia of injected mice. Biochemical characterization of the secreted αSyn revealed that, in cultured cells, this protein is released to the extracellular milieu via conventional secretion. The released αSyn is then internalized and processed by acceptor cells via the endosome–lysosome pathway indicating that the secreted αSyn is cell-to-cell transmitted. The secreted αSyn is aggregation-prone and amyloidogenic, and when expressed in the brain of wild-type non-transgenic mice, it induces a Parkinson’s disease-like phenotype that includes a robust αSyn pathology in the substantia nigra, neuronal loss, neuroinflammation, and motor deficits, all the key features of experimental animal models of Parkinson’s disease. In summary, a novel animal model of Parkinson’s disease based on enhanced cell-to-cell transmission of αSyn was developed. The neuron-produced cell-to-cell transmitted αSyn triggers all phenotypic features of experimental Parkinson’s disease in mice.

neurosciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop a new animal model of Parkinson's disease in order to study the inter - cellular propagation mechanism of α - synuclein (αSyn) and its impact on disease progression. Specifically, the authors enhanced the secretion and inter - cellular transfer ability of αSyn by fusing a removable short signal peptide (sp) at the N - terminus of αSyn and expressed it in the brains of wild - type non - transgenic mice. This model can simulate the key features of Parkinson's disease, including αSyn pathology, neuronal loss, neuroinflammation and movement disorders, thus providing a valuable tool for understanding the pathogenesis of Parkinson's disease and searching for treatment strategies.

### Main research background
Parkinson's disease is a common neurodegenerative disease. Its pathological features include a large number of losses of dopaminergic neurons and the abnormal accumulation of α - synuclein (αSyn) in neurons to form Lewy bodies. The inter - cellular propagation of αSyn is considered to be an important factor leading to the progression of Parkinson's disease. However, most of the existing animal models rely on the injection of exogenous αSyn and cannot fully simulate the natural production and propagation process of αSyn in vivo.

### Research methods
1. **Constructing cell models**: By fusing two different signal peptides (sp1 and sp2) at the N - terminus of αSyn, the authors constructed cell models that can efficiently secrete αSyn in cell culture.
2. **Verifying secretion and endocytosis**: Through Western blot and confocal microscopy techniques, it was confirmed that these αSyn variants can be secreted into the extracellular environment and endocytosed by other cells.
3. **Evaluating cytotoxicity**: The cytotoxicity of different αSyn variants was evaluated by MTT assay.
4. **Constructing mouse models**: Adeno - associated virus (AAV9) was used to express sp2 - αSyn in the midbrain neurons of mice to observe its in - vivo propagation and pathological effects.

### Main findings
1. **Enhanced secretion and inter - cellular propagation**: sp2 - αSyn can be efficiently secreted in cell culture and endocytosed by other cells to form stable high - molecular - weight (HMW) species.
2. **Cytotoxicity**: sp2 - αSyn shows significant cytotoxicity in cell culture.
3. **Pathological features in mouse models**: In the mouse model, the expression of sp2 - αSyn led to the typical pathological features of Parkinson's disease, including αSyn pathology, neuronal loss, neuroinflammation and movement disorders.

### Conclusion
By developing this new mouse model based on enhanced αSyn inter - cellular propagation, researchers can more realistically simulate the pathological process of Parkinson's disease, providing an important tool for disease mechanism research and new drug development.